These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 17587845)

  • 1. Exacerbation of pityriasis rubra pilaris under efalizumab therapy.
    Klein A; Szeimies RM; Landthaler M; Karrer S
    Dermatology; 2007; 215(1):72-5. PubMed ID: 17587845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical improvement of pityriasis rubra pilaris with efalizumab in a pediatric patient.
    Gómez M; Ruelas ME; Welsh O; Arcaute HD; Ocampo-Candiani J
    J Drugs Dermatol; 2007 Mar; 6(3):337-9. PubMed ID: 17373198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of atypical adult pityriasis rubra pilaris with oral alitretinoin.
    Pampín A; Gómez-de la Fuente E; Caro Gutiérrez MD; López-Estebaranz JL
    J Am Acad Dermatol; 2013 Aug; 69(2):e105-6. PubMed ID: 23866882
    [No Abstract]   [Full Text] [Related]  

  • 4. Erythrodermic pityriasis rubra pilaris: Dramatic response to infliximab therapy.
    Karadag AS; Kavala M; Ozlu E; Ozkanlı S; Zindancı İ; Turkoglu Z
    Indian J Dermatol Venereol Leprol; 2016; 82(1):112. PubMed ID: 26728835
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of Ixekizumab Treatment for Patients With Pityriasis Rubra Pilaris: A Single-Arm Trial.
    Haynes D; Strunck JL; Topham CA; Ortega-Loayza AG; Kent G; Cassidy PB; Hu R; Choate K; Wang Z; Liu Y; Greiling TM
    JAMA Dermatol; 2020 Jun; 156(6):668-675. PubMed ID: 32293641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of juvenile circumscribed pityriasis rubra pilaris to topical tazarotene treatment.
    Karimian-Teherani D; Parissa M; Tanew A
    Pediatr Dermatol; 2008; 25(1):125-6. PubMed ID: 18304175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secukinumab emerges as a rapidly effective therapy for pityriasis rubra pilaris.
    Bonomo L; Levitt JO
    Cutis; 2018 May; 101(5):367-369. PubMed ID: 29894526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adalimumab for the treatment of pityriasis rubra pilaris: a case report.
    Wassef C; Lombardi A; Rao BK
    Cutis; 2012 Nov; 90(5):244-7. PubMed ID: 23270195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of type I adult-onset pityriasis rubra pilaris with infliximab.
    Manoharan S; White S; Gumparthy K
    Australas J Dermatol; 2006 May; 47(2):124-9. PubMed ID: 16637810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of refractory adult-onset pityriasis rubra pilaris with TNF-alpha antagonists: a case series.
    Garcovich S; Di Giampetruzzi AR; Antonelli G; Garcovich A; Didona B
    J Eur Acad Dermatol Venereol; 2010 Aug; 24(8):881-4. PubMed ID: 20002243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pityriasis rubra pilaris. Case reports and review of the literature].
    Artik S; Megahed M; Ruzicka T
    Hautarzt; 2003 Sep; 54(9):858-63. PubMed ID: 12955264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pityriasis rubra pilaris].
    Artik S; Kuhn A; Neumann NJ; Ruzicka T; Megahed M
    Hautarzt; 2004 Oct; 55(10):980-3. PubMed ID: 15365642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infliximab for the treatment of adult-onset pityriasis rubra pilaris.
    Liao WC; Mutasim DF
    Arch Dermatol; 2005 Apr; 141(4):423-5. PubMed ID: 15837858
    [No Abstract]   [Full Text] [Related]  

  • 14. Pityriasis rubra pilaris, type 1.
    Booth AV; Ma L
    Dermatol Online J; 2005 Dec; 11(4):9. PubMed ID: 16403381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of pityriasis rubra pilaris with adalimumab - case report.
    Bravo EA; Carrion L; Paucar SM; Mendoza R; Rivera C
    Dermatol Online J; 2014 Apr; 20(4):22374. PubMed ID: 24746310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late onset pityriasis rubra pilaris type IV treated with low-dose acitretin.
    Mota F; Carvalho S; Sanches M; Selores M
    Acta Dermatovenerol Alp Pannonica Adriat; 2016; 25(1):15-7. PubMed ID: 27014774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate treatment in a case of juvenile pityriasis rubra pilaris.
    Boyd AH; Polcari IC
    Pediatr Dermatol; 2018 Jan; 35(1):e62-e63. PubMed ID: 29044698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of pityriasis rubra pilaris (type 1) under combination of infliximab and methotrexate.
    Barth D; Harth W; Treudler R; Simon JC
    J Dtsch Dermatol Ges; 2009 Dec; 7(12):1071-4. PubMed ID: 19689446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type I pityriasis rubra pilaris: upregulation of tumor necrosis factor alpha and response to adalimumab therapy.
    Zhang YH; Zhou Y; Ball N; Su MW; Xu JH; Zheng ZZ
    J Cutan Med Surg; 2010; 14(4):185-8. PubMed ID: 20642989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pityriasis rubra pilaris.
    White KL
    Dermatol Online J; 2003 Oct; 9(4):6. PubMed ID: 14594579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.